A Breakthrough for Depression Treatment: FDA Fast Tracks atai’s Novel Nasal Spray
The FDA has granted Breakthrough Therapy designation to BPL-003, a nasal spray that could transform treatment for patients whose depression
Read More
The FDA has granted Breakthrough Therapy designation to BPL-003, a nasal spray that could transform treatment for patients whose depression
Read More